Company Overview of Atomic Energy of Canada Limited
Atomic Energy of Canada Limited operates and manages nuclear laboratories. Atomic Energy of Canada Limited was formerly known as Crown Corporation. The company was founded in 1952 and is based in Oakville, Canada with an information and privacy office in Ottawa, Canada.
2030 Bristol Circle
Oakville, ON L6H 0H2
Founded in 1952
Key Executives for Atomic Energy of Canada Limited
Chief Financial Officer and Vice President
Chief Nuclear Officer and Vice President of Operations
Chief Technology Officer and Senior Vice President
Compensation as of Fiscal Year 2014.
Atomic Energy of Canada Limited Key Developments
Isowater and Atomic Energy of Canada Limited Sign Deuterium Oxide (Heavy Water) Marketing and Collaboration Agreement
Feb 27 14
Isowater Corporation (Isowater) and Atomic Energy of Canada Limited (AECL) announced the signing of an agreement to advance deuterium oxide (heavy water) technology and sales. The two firms have been collaborating since 2009 demonstrating deuterium oxide technology and selling deuterium oxide to the growing number of users in the high tech, life science and environmental sectors. This agreement marks a major milestone in their efforts. The agreement enables Isowater to market and sell existing deuterium oxide inventories to certain non-nuclear markets, while advancing new technologies designed to recycle and upgrade deuterium oxide. This upgrading of deuterium oxide will be accomplished using a refinery system developed in collaboration with AECL. In the longer term, Isowater will be developing new primary heavy water production systems to ensure availability of high quality virgin deuterium oxide as world supplies continue to dwindle.
Nordion Inc. Reaches Settlement with Atomic Energy of Canada Limited to Resolve MAPLE Lawsuits and Arbitration Costs
Aug 20 13
Nordion Inc. announced that Nordion and Atomic Energy of Canada Limited (AECL) have entered into a comprehensive settlement agreement to resolve the outstanding claims between both parties related to the MAPLE facilities. Nordion has also announced that, effective immediately, the parties have entered into an amended and restated isotope supply agreement and a waste management services agreement. Under the terms of the settlement agreement, Nordion will receive CAD 15 million in cash from AECL, and AECL has released its claim against Nordion of approximately CAD 47 million for arbitration costs. Nordion has correspondingly withdrawn its MAPLE-related lawsuit against AECL in relation to the Isotope Production Facilities Agreement (IPFA) and the parties have released each other from claims relating to the IPFA and related litigation. The release of claims includes Nordion's claim for damages against AECL under the IPFA of approximately CAD 244 million and AECL's IPFA counterclaim for damages against Nordion of CAD 80 million. The amended and restated isotope supply agreement is a non-exclusive agreement for medical isotope supply by AECL to Nordion, which has a term ending October 31, 2016. The supply agreement may also be terminated upon, among other things, Nordion establishing a satisfactory alternative supply of isotopes, the permanent shutdown of AECL's isotope production facilities, Nordion's failure to meet a minimum purchase quantity and any force majeure that continues for a period of more than two years. The primary cost of supply of medical isotopes will continue to be determined based on a revenue share methodology. Starting in 2014, the percentage of revenue share that AECL receives each year will increase throughout the term of the supply agreement contributing to a mid single-digit decrease in Nordion's Medical Isotopes gross margin percentage over the course of the contract. In addition, Nordion has entered into an agreement to continue waste disposal services from AECL until October 31, 2026.
Atomic Energy of Canada Limited Appoints James Hall to the Board of Directors, Effective August 1, 2013
Jul 31 13
Canada's Minister of Natural Resources announced the appointment of James Hall to the Board of Directors of Atomic Energy of Canada Limited. Mr. Hall has been a member of the Board of Directors of Indigo Books & Music Inc. for 14 years. He chairs its Human Resources and Compensation Committee and is a member of the Audit and Corporate Governance Committees. He is also on the Board of Directors of Immunovaccine Inc. This appointment, which is effective August 1, 2013, follows the February 28, 2013, announcement of the second phase of AECL restructuring that will launch a competitive procurement process for private sector management and operation of the AECL Laboratories.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|